[Selective cannabinoid receptor antagonists].
Kreutz
Susanne
S
Universitätsklinikum der Universität Frankfurt.
Korf
Horst-Werner
HW
Schubert-Zsilavecz
Manfred
M
D000818:Animals; D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D063387:Cannabinoid Receptor Antagonists; D063385:Cannabinoid Receptor Modulators / Q000096:biosynthesis / Q000502:physiology*; D002450:Cell Communication; D006801:Humans; D009765:Obesity / Q000188:drug therapy* / Q000503:physiopathology; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use*; D011720:Pyrazoles / Q000494:pharmacology / Q000627:therapeutic use*; D000077285:Rimonabant; D015398:Signal Transduction
D019440:Anti-Obesity Agents; D063387:Cannabinoid Receptor Antagonists; D063385:Cannabinoid Receptor Modulators; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant